The settlement removes a significant litigation overhang for Corteva, resolving statewide PFAS claims in North Carolina with a known, structured payment over 15 years. Monitor for the Effective Date (dismissals becoming final) and any Chemours credit or liquidity issues that could trigger the payment guarantees or Reserve Fund provisions.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20- T+0 · Sep 10 $84.49entry
- T+1 · 2mo ago −0.70%α −1.55% · $83.90
- T+5 · 2mo ago −3.50%α −4.13% · $81.53
- T+20 · 6w ago +8.47%α +6.34% · $91.64
- T+47 · todayOpen
- T+60 · in 17d Pending
Price Chart
How similar events traded
Executive Summary
Corteva, Inc. and its subsidiary EIDP, Inc., together with Chemours and DuPont, have reached a comprehensive settlement with the State of North Carolina and multiple local subdivisions to resolve all PFAS-related claims arising from the historic Fayetteville Works site. Under the settlement, the companies will collectively pay $455 million over 15 years, with Corteva's share being approximately $66 million. Additionally, Corteva and DuPont are required to guarantee Chemours' share of the settlement payments and establish a $135 million reserve fund to assure Chemours' remaining obligations under the existing Consent Order.
Key Facts
- Total settlement amount is $455 million paid over 15 years.
- Corteva's share is approximately $66 million (14.5% of the total).
- Corteva and DuPont guarantee Chemours' share of payments (29% and 71% respectively).
- A $135 million Reserve Fund is to be established for Chemours' remaining Consent Order obligations.
- The settlement resolves all Released Claims, including the Attorney General North Carolina Action and the Cumberland County action, which will be dismissed with prejudice.
- Initial payments of $102.5 million ($25M to State, $77.5M to subdivisions) are due within 30 days of the Execution Date (September 9, 2026).
Financial Impact
Corteva's direct cash payment is ~$66 million but it also bears contingent liability for 29% of Chemours' defaulted payments and 29% of a $135M reserve fund.
Risk Factors
- Chemours financial or operational distress could trigger Corteva's guarantee of Chemours' settlement payments (29% share of defaulted amounts).
- Future Credit-Eligible Claims may reduce the State's share of annual payments but could indicate additional litigation activity.
- Potential for a Multistate Settlement within 5 years that could affect North Carolina's recovery and scope of releases.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-387254 |
| Document: d121501d8k.htm | 0001193125-26-387254 |
| Document: 0001193125-26-387254-index-headers.html | 0001193125-26-387254 |
| Document: 0001193125-26-387254-index.html | 0001193125-26-387254 |
| Document: 0001193125-26-387254.txt | 0001193125-26-387254 |
Track record
28 reports on CTVA
0 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +9.51% at T+60 after the May 5, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Neutral 2/10 Entry $9.43 to $9.04 Now $9.04 −4.14% ▼ −4.14% −2.22% vs SPY
- Nov 12, 20264d ago 8-K Bearish 6/10 Entry $9.19 to $9.43 Now $9.04 +1.63% ▼ −2.61% −2.97% vs SPY
- Nov 10, 20266d ago NT 10-Q Neutral 4/10 Entry $12.14 to $9.19 Now $9.04 −25.54% ▼ −24.30% −23.95% vs SPY
- Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $11.90 to $12.11 Now $9.04 −24.03% ▲ +1.76% −0.60% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $12.04 to $11.90 Now $9.04 −24.92% ▼ −1.16% −1.48% vs SPY
- Nov 4, 202612d ago SC 13G/A Neutral 3/10 Entry $12.04 to $11.90 Now $9.04 −24.92% ▼ −1.16% −1.48% vs SPY
- Oct 28, 202619d ago Institutional Cluster Mixed 3/10 Entry $11.33 to $11.47 Now $9.04 −20.21% ▲ +1.24% +1.62% vs SPY
- Oct 23, 202624d ago Press Release Neutral 2/10 Entry $12.45 to $11.95 Now $9.04 −27.39% ▼ −4.02% −4.73% vs SPY
- Oct 13, 20264w ago 8-K Bearish 6/10 Entry $13.36 to $13.40 Now $9.04 +32.34% ▼ −0.30% −1.38% vs SPY
- Oct 5, 20266w ago 3 Neutral 2/10 Entry $13.91 to $14.45 Now $9.04 −35.01% ▲ +3.88% +4.12% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers